VIVO OPPORTUNITY, LLC reported 3 transactions at SIERRA ONCOLOGY, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
+25K
Price / share
$13.20
Trade value
$329.95K
% of position
Common Stock
Shares
+480.28K
Price / share
$13.20
Trade value
$6.34M
% of position
Common Stock
Shares
+107.16K
Price / share
$13.20
Trade value
$1.41M
% of position
Net shares
+612.44K
Net value
$8.08M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/26/2022 | X · X | +25K | $13.20 | $329.95K | 18.3% | 136.72K | 161.71K |
| Common Stock Indirect | 1/26/2022 | X · X | +480.28K | $13.20 | $6.34M | 33.0% | 1.46M | 1.94M |
| Common Stock Indirect | 1/26/2022 | X · X | +107.16K | $13.20 | $1.41M | 33.0% | 324.78K | 431.95K |
| Total | +612.44K | $8.08M | ||||||
Series B Warrant (Right to Purchase )
Common Stock
25K shares
Shares
−75.75K
Strike price
13.20
Held after
0.00
Exercisable
—
Series B Warrant (Right to Purchase )
Common Stock
480.28K shares
Shares
−1.46M
Strike price
13.20
Held after
0.00
Exercisable
—
Series B Warrant (Right to Purchase )
Common Stock
107.16K shares
Shares
−324.74K
Strike price
13.20
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Warrant (Right to Purchase ) Indirect | Common Stock25K shares | 1/26/2022 | X · X | −75.75K | 13.20 | — | 0.00 |
| Series B Warrant (Right to Purchase ) Indirect | Common Stock480.28K shares | 1/26/2022 | X · X | −1.46M | 13.20 | — | 0.00 |
| Series B Warrant (Right to Purchase ) Indirect | Common Stock107.16K shares | 1/26/2022 | X · X | −324.74K | 13.20 | — | 0.00 |